Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...

The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...

The Schmidts' philanthropic research organization will build a 3-meter space telescope and fund three ground-based facilities.